欢迎来到天天文库
浏览记录
ID:54588596
大小:312.74 KB
页数:4页
时间:2020-05-02
《全天麻胶囊联合缬沙坦治疗原发性高血压的临床观察.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、现代生物医学进展wwwahengwuyixue~omProgressinModernBiomedicineVoL12N0.32NOV.2012·633I·全天麻胶囊联合缬沙坦治疗原发性高血压的临床观察刘英刘小军廖贻刚汤湘江。(I湖南武冈市人民医院湖南武冈422400;2广州中医药大学第二临床医学院广东广州510120)摘要目的:观察全天麻胶囊联合缬沙坦治疗原发性高血压的临床疗效。方法:将100例轻、中度原发性高血压病患者,随机分为治疗组与对照组,每组各50例,对照组口服缬沙坦片,80mg/次,1次/日,治疗组除口服缬沙坦片外(用法同对照组),加
2、服全天麻胶囊,4粒/次,3次/d,每4周为1个疗程,3个疗程后判定疗效。观察治疗前后的临床疗效及血压下降程度。结果:治疗结束后,治疗组总有效率为94%,对照组总有效率为82%,两组比较差异具有统计学意义(P3、显,差异具有统计学意义(P<0.o5)。结论:全天麻胶囊联合缬沙坦治疗原发性轻、中度高血压痛具有较高的临床疗效。关键词:全天麻胶囊;缬沙坦;原发性高血;hs-CRP中图分类号:R743.2文献标识码:A文章编号:1673—6273(2012)32—6331-04ClinicalObservationontheTreatmentofEssentialHypertensionbyFullr1nl’anma/一’apsu1leanQ11VTa1lsartanL/UYingl,L1UXiao-jud,LbtOYi-gan~,TANGXiang-jian4、ge(1People'sHospitalofWugangcig/,WugangHunanprovince,422400;2SecondClinicalMedicalcollege,OuangzhouUniversityofChineseMedicine,GuangdongGuangzhou,510120)ABSTRACTObjective:ToobservethefullTianmacapsulecombinedwithValsartantreatmentofessentialhypertensioninpatientswiththeefica5、cyofantihypertensiveefect.Methods:100patientswithmildtomoderateessentialhypertensionwererandomlydividedintotreatanentgroupandcontrolgroup,50patientsinthecontrolgroupwastreatedwithvalsartantablets,80mg/times,1time/day.thetreatmentgrouptreatedwithvalsartan—chip(usingthesamecon6、trolgroup)plusfullTianmacapsules4capsules7、times,3times8、devery4weeksforacourseoftreatment,after3treatmenttodetermineeficacy.Observedbeforeandaftertreatmentoftheclinicaleficacyandbloodpressureleve1.Results:Aftertreatment,totaleffectiveratewas94%inthetreatmentgroup,totalefectiv9、eratewas82%inthecontrolgroup,thediferencewasstatisticallysignificant(P<0.05);aftertreatment,thetreatmentgroupandcontrolgroupofbloodrheologymarkerswereimproved,comparedwiththecontrolgroup,treatmentgrouptotalcholesterol,triglycerides,LDLdecreasedmoresignificantlythanthecontrol10、group,thediferencewasstatisticallysignificant(P<0.05).Aftertreatment,thetre
3、显,差异具有统计学意义(P<0.o5)。结论:全天麻胶囊联合缬沙坦治疗原发性轻、中度高血压痛具有较高的临床疗效。关键词:全天麻胶囊;缬沙坦;原发性高血;hs-CRP中图分类号:R743.2文献标识码:A文章编号:1673—6273(2012)32—6331-04ClinicalObservationontheTreatmentofEssentialHypertensionbyFullr1nl’anma/一’apsu1leanQ11VTa1lsartanL/UYingl,L1UXiao-jud,LbtOYi-gan~,TANGXiang-jian
4、ge(1People'sHospitalofWugangcig/,WugangHunanprovince,422400;2SecondClinicalMedicalcollege,OuangzhouUniversityofChineseMedicine,GuangdongGuangzhou,510120)ABSTRACTObjective:ToobservethefullTianmacapsulecombinedwithValsartantreatmentofessentialhypertensioninpatientswiththeefica
5、cyofantihypertensiveefect.Methods:100patientswithmildtomoderateessentialhypertensionwererandomlydividedintotreatanentgroupandcontrolgroup,50patientsinthecontrolgroupwastreatedwithvalsartantablets,80mg/times,1time/day.thetreatmentgrouptreatedwithvalsartan—chip(usingthesamecon
6、trolgroup)plusfullTianmacapsules4capsules
7、times,3times
8、devery4weeksforacourseoftreatment,after3treatmenttodetermineeficacy.Observedbeforeandaftertreatmentoftheclinicaleficacyandbloodpressureleve1.Results:Aftertreatment,totaleffectiveratewas94%inthetreatmentgroup,totalefectiv
9、eratewas82%inthecontrolgroup,thediferencewasstatisticallysignificant(P<0.05);aftertreatment,thetreatmentgroupandcontrolgroupofbloodrheologymarkerswereimproved,comparedwiththecontrolgroup,treatmentgrouptotalcholesterol,triglycerides,LDLdecreasedmoresignificantlythanthecontrol
10、group,thediferencewasstatisticallysignificant(P<0.05).Aftertreatment,thetre
此文档下载收益归作者所有